
Join to view full profile
16 Woodbine LnDanville, PA 17821
Phone+1 570-271-6531
Fax+1 570-271-7146
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nathalie Guibord, MD is a board certified ophthalmologist in Danville, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, New Mexico, and New Mexico.
Education & Training
UPMC Medical EducationResidency, Ophthalmology, 1996 - 1999
McGill University Faculty of MedicineClass of 1994
Certifications & Licensure
PA State Medical License 1997 - 2026
PA State Medical License 1999 - 2026
NM State Medical License 1998 - 2004
NM State Medical License 1998 - 2004
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
Publications & Presentations
PubMed
- Iritis and iris neoplasm as the presenting signs of esophageal squamous cell carcinoma.Kendall R. B. Dobbins, Amy A. Zguta, Robert J. Kupsho, Tamara R. Vrabec, Nathalie M. Guibord
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2009-08-01 - 30 citationsCorneal endothelial cell loss after multiple vitreoretinal procedures and the use of silicone oil.Thomas R. Friberg, Nathalie M Guibord
Ophthalmic Surgery and Lasers. 1999-07-01
Press Mentions
Geisinger Honors 195 Providers for High Patient Satisfaction RatingsJanuary 4th, 2022









